3SBio Inc. is a prominent biotechnology company primarily engaged in the research, development, manufacturing, and commercialization of biopharmaceutical products. Its core focus lies in developing in... 3SBio Inc. is a prominent biotechnology company primarily engaged in the research, development, manufacturing, and commercialization of biopharmaceutical products. Its core focus lies in developing innovative treatment options for patients suffering from cancer, nephrology, and autoimmune diseases. Notably, the company produces erythropoietin, a hormone crucial for red blood cell production, which positions it as a key player in the treatment of anemia caused by chronic kidney disease and chemotherapy. 3SBio also explores cutting-edge therapies, including monoclonal antibodies and other biologics, highlighting its commitment to advancing healthcare solutions. This company plays an integral role in the biotechnology sector by contributing to the availability of affordable and effective medicines, especially within the Chinese healthcare system where it is based. Its strategic operations, extensive portfolio, and research initiatives ensure its significance in addressing unmet medical needs and enhancing patient quality of life. Founded in 1993, 3SBio continues to expand its influence in Asia and globally by collaborating with international partners and leveraging advancements in biotechnological research and development.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Financial Fundamentals data not yet covered for 3SBio

We have not yet reviewed 3SBio's disclosures for Financial Fundamentals data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review 3SBio's data?

Start your 30-day free trial to request a data review for 3SBio.

Start Free Trial

Legal Center Contact Us